{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:33:29Z","timestamp":1790897609824,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3081,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/mt.2008.48","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T18:27:54Z","timestamp":1207247274000},"page":"871-878","source":"Crossref","is-referenced-by-count":23,"title":["Systemic Osteoprotegerin Gene Therapy Restores Tumor-induced Bone Loss in a Therapeutic Model of Breast Cancer Bone Metastasis"],"prefix":"10.1016","volume":"16","author":[{"given":"Diptiman","family":"Chanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Isayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene P","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April A","family":"Szafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt R","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu VB","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvarangan","family":"Ponnazhagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.48_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/mt.2008.48_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy","volume":"10","author":"Kozlow","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1038\/mt.2008.48_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2008.48_bib4","first-page":"49","article-title":"RANKL\/RANK\/OPG: new therapeutic targets in bone tumours and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2008.48_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ncponc0381","article-title":"Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis","volume":"3","author":"Blair","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/mt.2008.48_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","article-title":"The RANK\/RANKL\/OPG triad in cancer-induced bone diseases","volume":"25","author":"Dougall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/mt.2008.48_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14737140.7.2.221","article-title":"Key roles of the OPG-RANK-RANKL system in bone oncology","volume":"7","author":"Baud'huin","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/mt.2008.48_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2008.48_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1038\/mt.2008.48_bib10","first-page":"783","article-title":"Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy","volume":"60","author":"Capparelli","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2008.48_bib12","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib13","first-page":"287","article-title":"Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma","volume":"63","author":"Vanderkerken","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.103.057893","article-title":"Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption","volume":"309","author":"Onyia","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2008.48_bib15","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1210\/en.2004-1583","article-title":"The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy","volume":"146","author":"Morony","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/mt.2008.48_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20050175","article-title":"Role of osteoprotegerin (OPG) in cancer","volume":"110","author":"Holen","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/mt.2008.48_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10585-006-9008-z","article-title":"The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice","volume":"23","author":"Tannehill-Gregg","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/mt.2008.48_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/mt.2008.48_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.cgt.7700876","article-title":"Adeno-associated virus vectors: potential applications for cancer gene therapy","volume":"12","author":"Li","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2008.48_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/1078-0432.1342.11.3","article-title":"Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intra-peritoneal ovarian cancer","volume":"11","author":"Isayeva","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2008.48_bib21","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1158\/0008-5472.CAN-06-3637","article-title":"Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model","volume":"67","author":"Isayeva","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-005-2419-8","article-title":"Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo \u2014a role in tumor cell survival?","volume":"92","author":"Holen","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/mt.2008.48_bib23","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1158\/0008-5472.CAN-05-3119","article-title":"Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically","volume":"66","author":"Fisher","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcb.10746","article-title":"Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation","volume":"91","author":"Mastro","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1038\/mt.2008.48_bib25","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/art.10527","article-title":"Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model","volume":"46","author":"Yang","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2008.48_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bone.2003.12.006","article-title":"Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice","volume":"34","author":"Kostenuik","year":"2004","journal-title":"Bone"},{"key":"10.1038\/mt.2008.48_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bone.2005.07.021","article-title":"Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties","volume":"37","author":"Ulrich-Vinther","year":"2005","journal-title":"Bone"},{"key":"10.1038\/mt.2008.48_bib28","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-04-2033","article-title":"steoprotegerin in prostate cancer bone metastasis","volume":"65","author":"Corey","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bone.2006.09.016","article-title":"Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis","volume":"40","author":"Zheng","year":"2007","journal-title":"Bone"},{"key":"10.1038\/mt.2008.48_bib30","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1158\/0008-5472.CAN-06-4130","article-title":"Therapeutic relevance of OPG gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption","volume":"67","author":"Lamoureux","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.48_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/mt.2008.48_bib32","first-page":"2471","article-title":"A model for osseous metastasis of human breast cancer established by intra-femur injection of the MDA-MB-435 cells in nude mice","volume":"17","author":"Wang","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1038\/mt.2008.48_bib33","series-title":"Current Protocols in Molecular Biology","first-page":"1","article-title":"Introduction of DNA into mammalian cells","author":"Kingston","year":"2001"},{"key":"10.1038\/mt.2008.48_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0378-1119(99)00347-9","article-title":"A helper virus-free packaging system for recombinant adeno-associated virus vectors","volume":"238","author":"Collaco","year":"1999","journal-title":"Gene"},{"key":"10.1038\/mt.2008.48_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.48_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/hum.1997.8.3-275","article-title":"Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells","volume":"8","author":"Ponnazhagan","year":"1997","journal-title":"Hum Gene Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616317002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616317002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T13:03:23Z","timestamp":1684328603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616317002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1525001616317002"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.48","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}